Delivery Order SPE2DB22D1106-SPE2DB25FFHU1
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,069.16 to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled for completion by September 10, 2025. The order was placed on September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $2,840.04 to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of July 30, 2025. The contract carries no set-aside designation, meaning it was competed among all eligible vendors. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities, valued at $6,768.50. This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,524.40, is for the delivery of Calcipotriene 0.005% Solution, a topical medication, with an ultimate completion date of April 2, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,294.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Calcipotriene 0.005% solution (60ml). This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to provide pharmaceutical products and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,335.84 firm fixed-price delivery order is for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML, a pharmaceutical product, with a period of performance through May 30, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,487.84 firm fixed-price delivery order is for the supply of Calcipotriene 0.005% Solution, a topical medication. The contract has an ultimate completion date of April 4, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a $2,989.18 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CALCIPOTRIENE 0.005% SOLUTION 60ML. The contract has a completion date of July 10, 2025 and is not set aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle...
- This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Calcipotriene 0.005% Solution 60ML, a medication, with a ceiling value of $1,524.40 and a performance period ending on May 19, 2025. The contract is not set-aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $64,110 firm fixed price delivery order to Amerisourcebergen Drug Corporation for calcipotriene 0.005% cream in 60 gram quantities. The single award delivery order is under an indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen to supply pharmaceutical products to DLA. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September 8 through September 11, 2023. No...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFHU1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,727.62 to AmerisourceBergen Drug Corp for the supply of Calcipotriene 0.005% Solution in 60ml quantities. The contract was competitively awarded on September 9, 2025, with an ultimate completion date of September 10, 2025, and utilizes firm fixed pricing. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle active through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying medications and medical supplies to military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates extensive experience fulfilling diverse pharmaceutical requirements across multiple therapeutic domains through competitively awarded delivery orders with consistent firm fixed pricing structures.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/9/25 |